Risk factors for recurrent respiratory tract infection in children and predictive values of MCP-1,miR-146a and miR-155
OBJECTIVE To analyze the risk factors for recurrent respiratory tract infection in the children and ob-serve the predictive values of monocyte chemoattractant protein-1(MCP-1),micro ribonucleic acid(miR)-146a and miR-155.METHODS A total of 204 children with respiratory tract infection who were treated in Xiantao First People's Hospital Affiliated to Changjiang University from Jan 2020 to Jul 2022 were enrolled in the study,67 of whom had recurrent respiratory tract infection and were assigned as the study group,the rest of 137 children who had the occasional infection or did not meet the diagnostic criteria for recurrent respiratory tract infection were as-signed as the control group.The risk factors for the recurrent respiratory tract infection were concluded.The val-ues of MCP-1,miR-146a and miR-155 in prediction of the recurrent respiratory tract infection were analyzed by means of receiver operating characteristic(ROC)curves.RESULTS Among the 204 children with respiratory tract infection,67 had recurrent respiratory tract infection,accounting for 32.84%.The result of multivariate logistic analysis showed that less than 6 months of breast feeding,less than 1.5 hours of outdoor activity per day,passive exposure to tobacco,house decoration time less than 1 year and ill-balanced diet were the risk factors for the recur-rent respiratory tract infection in the children(P<0.05).The expression levels of MCP-1,miR-146a and miR-155 of the study group were higher than those of the control group(P<0.05).ROC curve analysis showed that the joint detection of MCP-1,miR-146a and miR-155 had high clinical value in prediction of recurrent respiratory tract infection,with the area under curve(AUC)0.902.CONCLUSION There are a variety of risk factors for the re-current respiratory tract infection in the children.The joint detection of MCP-1,Mir-146a and miR-155 has high clinical value in prediction of the recurrent respiratory tract infection,which can be used as a new target for clinical diagnosis and treatment.